Back to trial detailsIntake questionnaire
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Applying to UT Health Mays Cancer Center · San Antonio, Texas
Answer a few short questions to share with the research team.
0 of 3 answered